Enanta Pharmaceuticals (ENTA) Price to Sales (2013 - 2026)
Enanta Pharmaceuticals' (ENTA) Price to Sales came in at 6.51 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 160.9% from 2.49 a year earlier and up 22.7% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Price to Sales (2013 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Price to Sales stood at 3.92, up 20.7% from FY2024.
- In prior fiscal years, Enanta Pharmaceuticals' Price to Sales was 3.25 in FY2024 (+9.3%), 2.97 in FY2023 (-76.3%), 12.52 in FY2022 (+5.7%) and 11.84 in FY2021 (+57.8%).
- Quarterly Price to Sales has run from a low of 1.83 in fiscal Q2 2025 to a high of 16.49 in fiscal Q1 2022 over five years.
- On a year-over-year basis, Price to Sales has increased in each of the last four quarters, with growth averaging 65.1% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was fiscal Q1 2026, with growth of 270.9%; the weakest was fiscal Q1 2024, with a decline of 77.1%.
- According to Business Quant data, Price to Sales for the three prior fiscal quarters was 5.30 (Q2 2026), 6.83 (Q1 2026) and 3.92 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.51 |
| Mar 31, 2026 | 5.30 |
| Dec 31, 2025 | 6.83 |
| Sep 30, 2025 | 3.92 |
| Jun 30, 2025 | 2.49 |
| Mar 31, 2025 | 1.83 |
| Dec 31, 2024 | 1.84 |
| Sep 30, 2024 | 3.25 |
| Jun 30, 2024 | 3.82 |
| Mar 31, 2024 | 5.07 |
| Dec 31, 2023 | 2.70 |
| Sep 30, 2023 | 2.97 |
| Jun 30, 2023 | 5.59 |
| Mar 31, 2023 | 10.49 |
| Dec 31, 2022 | 11.83 |
| Sep 30, 2022 | 12.52 |
| Jun 30, 2022 | 10.95 |
| Mar 31, 2022 | 16.03 |
| Dec 31, 2021 | 16.49 |
| Sep 30, 2021 | 11.84 |
API Access
Enanta Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();